D Umpierre1, P A B Ribeiro, B D Schaan, J P Ribeiro. 1. Exercise Pathophysiology Research Laboratory, Hospital de Clínicas de Porto Alegre, Rua Ramiro Barcelos 2350, Centro de Pesquisa Clínica-LaFiex, Porto Alegre, RS, Brazil. daniel.umpierre@gmail.com
Abstract
AIMS/HYPOTHESIS: Supervised exercise programmes improve glycaemic control in type 2 diabetes, but training characteristics associated with reduction in HbA(1c) remain unclear. We conducted a systematic review with meta-regression analysis of randomised clinical trials (RCTs) assessing the association between intensity and volume of exercise training (aerobic, resistance or combined) and HbA(1c) changes in patients with type 2 diabetes. METHODS: Five electronic databases were searched (1980-2012) to retrieve RCTs of at least 12 weeks' duration, consisting of supervised exercise training vs no intervention, that reported HbA(1c) changes and exercise characteristics. Two independent reviewers conducted study selection and data extraction. RESULTS: Twenty-six RCTs (2,253 patients) met the inclusion criteria. In multivariate analysis, baseline HbA(1c) and exercise frequency explained nearly 58% of between-study variance. Baseline HbA(1c) was inversely correlated with HbA(1c) reductions after the three types of exercise training. In aerobic training, exercise volume (represented by frequency of sessions) was associated with changes in HbA(1c) (weighted r = -0.64), while no variables were correlated with glycaemic control induced by resistance training. In combined training, weekly volume of resistance exercise explained heterogeneity in multivariate analysis and was associated with changes in HbA(1c) levels (weighted r = -0.70). CONCLUSIONS/ INTERPRETATION: Reduction in HbA(1c) is associated with exercise frequency in supervised aerobic training, and with weekly volume of resistance exercise in supervised combined training. Therefore, exercise volume is a major determinant of glycaemic control in patients with type 2 diabetes.
AIMS/HYPOTHESIS: Supervised exercise programmes improve glycaemic control in type 2 diabetes, but training characteristics associated with reduction in HbA(1c) remain unclear. We conducted a systematic review with meta-regression analysis of randomised clinical trials (RCTs) assessing the association between intensity and volume of exercise training (aerobic, resistance or combined) and HbA(1c) changes in patients with type 2 diabetes. METHODS: Five electronic databases were searched (1980-2012) to retrieve RCTs of at least 12 weeks' duration, consisting of supervised exercise training vs no intervention, that reported HbA(1c) changes and exercise characteristics. Two independent reviewers conducted study selection and data extraction. RESULTS: Twenty-six RCTs (2,253 patients) met the inclusion criteria. In multivariate analysis, baseline HbA(1c) and exercise frequency explained nearly 58% of between-study variance. Baseline HbA(1c) was inversely correlated with HbA(1c) reductions after the three types of exercise training. In aerobic training, exercise volume (represented by frequency of sessions) was associated with changes in HbA(1c) (weighted r = -0.64), while no variables were correlated with glycaemic control induced by resistance training. In combined training, weekly volume of resistance exercise explained heterogeneity in multivariate analysis and was associated with changes in HbA(1c) levels (weighted r = -0.70). CONCLUSIONS/ INTERPRETATION: Reduction in HbA(1c) is associated with exercise frequency in supervised aerobic training, and with weekly volume of resistance exercise in supervised combined training. Therefore, exercise volume is a major determinant of glycaemic control in patients with type 2 diabetes.
Authors: D Hansen; P Dendale; R A M Jonkers; M Beelen; R J F Manders; L Corluy; A Mullens; J Berger; R Meeusen; L J C van Loon Journal: Diabetologia Date: 2009-04-16 Impact factor: 10.122
Authors: J Kang; R J Robertson; J M Hagberg; D E Kelley; F L Goss; S G DaSilva; R R Suminski; A C Utter Journal: Diabetes Care Date: 1996-04 Impact factor: 19.112
Authors: Carmen Castaneda; Jennifer E Layne; Leda Munoz-Orians; Patricia L Gordon; Joseph Walsmith; Mona Foldvari; Ronenn Roubenoff; Katherine L Tucker; Miriam E Nelson Journal: Diabetes Care Date: 2002-12 Impact factor: 19.112
Authors: Joseph A Houmard; Charles J Tanner; Cris A Slentz; Brian D Duscha; Jennifer S McCartney; William E Kraus Journal: J Appl Physiol (1985) Date: 2003-09-12
Authors: Ronald J Sigal; Glen P Kenny; Normand G Boulé; George A Wells; Denis Prud'homme; Michelle Fortier; Robert D Reid; Heather Tulloch; Douglas Coyle; Penny Phillips; Alison Jennings; James Jaffey Journal: Ann Intern Med Date: 2007-09-18 Impact factor: 25.391
Authors: Jeremy D Goldhaber-Fiebert; Sara N Goldhaber-Fiebert; Mario L Tristán; David M Nathan Journal: Diabetes Care Date: 2003-01 Impact factor: 19.112
Authors: Jennifer L Jarvie; Ambarish Pandey; Colby R Ayers; Jonathan M McGavock; Martin Sénéchal; Jarett D Berry; Kershaw V Patel; Darren K McGuire Journal: Diabetes Care Date: 2019-05-21 Impact factor: 19.112
Authors: Eric J Shiroma; Nancy R Cook; Joann E Manson; M V Moorthy; Julie E Buring; Eric B Rimm; I-Min Lee Journal: Med Sci Sports Exerc Date: 2017-01 Impact factor: 5.411
Authors: Franciele R Figueira; Daniel Umpierre; Felipe V Cureau; Alessandra T N Zucatti; Mériane B Dalzochio; Cristiane B Leitão; Beatriz D Schaan Journal: Sports Med Date: 2014-11 Impact factor: 11.136
Authors: Dominique Hansen; Josef Niebauer; Veronique Cornelissen; Olga Barna; Daniel Neunhäuserer; Christoph Stettler; Cajsa Tonoli; Eugenio Greco; Robert Fagard; Karin Coninx; Luc Vanhees; Massimo F Piepoli; Roberto Pedretti; Gustavo Rovelo Ruiz; Ugo Corrà; Jean-Paul Schmid; Constantinos H Davos; Frank Edelmann; Ana Abreu; Bernhard Rauch; Marco Ambrosetti; Simona Sarzi Braga; Paul Beckers; Maurizio Bussotti; Pompilio Faggiano; Esteban Garcia-Porrero; Evangelia Kouidi; Michel Lamotte; Rona Reibis; Martijn A Spruit; Tim Takken; Carlo Vigorito; Heinz Völler; Patrick Doherty; Paul Dendale Journal: Sports Med Date: 2018-08 Impact factor: 11.136